AJOVY

This brand name is authorized in Austria, Brazil, Canada, Croatia, Cyprus, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, New Zealand, Poland, Romania, South Africa, Spain, Turkey, UK, United States.

Active ingredients

The drug AJOVY contains one active pharmaceutical ingredient (API):

1	Fremanezumab UNII PF8K38CG54 - FREMANEZUMAB
	Fremanezumab is a humanised IgG2Δa/kappa monoclonal antibody which selectively binds the calcitonin gene-related peptide (CGRP) ligand and blocks both CGRP isoforms (α- and β-CGRP) from binding to the CGRP receptor. It is believed that prevention of migraine is obtained by its effect modulating the trigeminal system.
	Read more about Fremanezumab

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
AJOVY Solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02CD03		N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CD Calcitonin gene-related peptide (CGRP) antagonists
Discover more medicines within N02CD03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	537520050008907, 537520050009007
CA	Health Products and Food Branch	02497859
EE	Ravimiamet	1791615, 1791626
ES	Centro de información online de medicamentos de la AEMPS	1191358001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	176721, 416492
FR	Base de données publique des médicaments	68696906
GB	Medicines & Healthcare Products Regulatory Agency	372224, 386539
HK	Department of Health Drug Office	67139
IE	Health Products Regulatory Authority	89094, 89109
IL	מִשְׂרַד הַבְּרִיאוּת	8464
JP	医薬品医療機器総合機構	1190407G1023, 1190407G2020
LT	Valstybinė vaistų kontrolės tarnyba	1087474, 1087475, 1089296, 1089297
NZ	Medicines and Medical Devices Safety Authority	21711
PL	Rejestru Produktów Leczniczych	100417464
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65973001, W65973002, W68419001, W68419002
TR	İlaç ve Tıbbi Cihaz Kurumu	8699638955701, 8699638955718
US	FDA, National Drug Code	51759-202, 51759-204
ZA	Health Products Regulatory Authority	54/30.1/0711